What does Regeneron Pharmaceuticals, Inc. do?
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide. The company develops product candidates to treat eye, allergic and inflammatory, cardiovascular, metabolic, neurological, infectious, and rare diseases; and cancer, hematologic…
What is Regeneron Pharmaceuticals, Inc.'s P/E and P/B ratio?
Regeneron Pharmaceuticals, Inc. has a P/E ratio of 20.3 and a P/B ratio of 2.66.
What is Regeneron Pharmaceuticals, Inc.'s debt-to-equity ratio?
Regeneron Pharmaceuticals, Inc. has a debt-to-equity ratio of 0.09.
How much does Regeneron Pharmaceuticals, Inc. owe compared with what it owns?
Regeneron Pharmaceuticals, Inc. owes $0.24 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Regeneron Pharmaceuticals, Inc.'s Positivity rank?
Regeneron Pharmaceuticals, Inc. is ranked #4,148 of 6,775 companies globally and #1,988 of 4,000 in United States on PositoAI, with a Positivity Score of 19,882.
Does Regeneron Pharmaceuticals, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Regeneron Pharmaceuticals, Inc..
Where can I read the latest news about Regeneron Pharmaceuticals, Inc.?
Recent headlines about Regeneron Pharmaceuticals, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Regeneron Pharmaceuticals, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Regeneron Pharmaceuticals, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.